These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 328021)

  • 1. [Studies on the urinary excretion of metabolites of valproic acid (dipropylacetic acid) in rats and humans (author's transl)].
    Kochen W; Imbeck H; Jakobs C
    Arzneimittelforschung; 1977; 27(5):1090-9. PubMed ID: 328021
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the enteral absorption of valproic acid (author's transl)].
    Oelkers W; Stoffels G; Schäfer H; Reith H
    Arzneimittelforschung; 1977; 27(5):1088-90. PubMed ID: 328020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic studies with valproic acid in man.
    Klotz U
    Arzneimittelforschung; 1977; 27(5):1085-8. PubMed ID: 328019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of valproate sodium in rabbit, rat, dog, and man.
    Ferrandes B; Eymard P
    Epilepsia; 1977 Jun; 18(2):169-82. PubMed ID: 326545
    [No Abstract]   [Full Text] [Related]  

  • 5. [The metabolism of dipropylacetic acid dipropylacetamide. I. Identification and analysis in the urine by gas phase chromatography].
    Pfaff MC; Mahuzier G
    Ann Pharm Fr; 1975; 33(6-7):355-63. PubMed ID: 769646
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of branched medium chain length fatty acid. II--beta-oxidation of sodium dipropylacetate in rats.
    Matsumoto I; Kuhara T; Yoshino M
    Biomed Mass Spectrom; 1976 Oct; 3(5):235-40. PubMed ID: 788806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of serum level of dipropylacetic acid sodium (Depakene) by gaschromatography (author's transl)].
    Hosokawa K; Kugoh T; Otsuki S
    No To Shinkei; 1977 Aug; 29(8):885-90. PubMed ID: 409421
    [No Abstract]   [Full Text] [Related]  

  • 8. Propionic acid and dipropylacetic acid in the urine of patients treated with dipropylacetic acid.
    Schmid RD
    Clin Chim Acta; 1977 Jan; 74(1):39-42. PubMed ID: 318945
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems in the treatment of a patient with longstanding epilepsy (author's transl)].
    Missoum A; Riche C; Guedes Y; Goas JY
    Sem Hop; 1981 Nov 18-25; 57(43-44):1869-72. PubMed ID: 6274040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic acids or urine in multiple sclerosis.
    Steen G; Ransnäs L
    Acta Neurol Scand; 1983 Oct; 68(4):231-40. PubMed ID: 6659864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the therapeutic action and side-effects of a new preparation of dipropylacetic acid].
    Gallassi R
    Clin Ter; 1977 Nov; 83(3):313-7. PubMed ID: 342177
    [No Abstract]   [Full Text] [Related]  

  • 13. Gas chromatography/negative ion chemical ionization mass spectrometry and liquid chromatography/electrospray ionization tandem mass spectrometry quantitative profiling of N-acetylcysteine conjugates of valproic acid in urine: application in drug metabolism studies in humans.
    Gopaul SV; Farrell K; Abbott FS
    J Mass Spectrom; 2000 Jun; 35(6):698-704. PubMed ID: 10862121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of valproic acid metabolites in human serum and urine using hexadeuterated valproic acid and gas chromatographic mass spectrometric analysis.
    Acheampong A; Abbott F; Burton R
    Biomed Mass Spectrom; 1983 Nov; 10(11):586-95. PubMed ID: 6419788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of sodium valproate in epileptic patients.
    Perucca E; Gatti G; Frigo GM; Crema A; Calzetti S; Visintini D
    Br J Clin Pharmacol; 1978 Jun; 5(6):495-9. PubMed ID: 350251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of valproic acid in patients with liver disease.
    Klotz U; Rapp T; Müller WA
    Eur J Clin Pharmacol; 1978 Mar; 13(1):55-60. PubMed ID: 346355
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of urinary metabolites of sodium dipropylacetate in man; potential sources of interference in organic acid screening procedures.
    Gompertz D; Tippett P; Bartlett K; Baillie T
    Clin Chim Acta; 1977 Jan; 74(2):153-60. PubMed ID: 318946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipropylacetate and propionyl CoA carboxylase.
    Wolf B
    Lancet; 1978 Aug; 2(8085):369. PubMed ID: 79729
    [No Abstract]   [Full Text] [Related]  

  • 19. Capillary gas chromatographic/mass spectrometric analysis of abnormal metabolites in hypoglycin-treated rat urine.
    Hine DG; Tanaka K
    Biomed Mass Spectrom; 1984 Jul; 11(7):332-9. PubMed ID: 6478044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired biliary elimination of beta-glucuronidase-resistant "glucuronides" of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers.
    Dickinson RG; Kluck RM; Wood BT; Eadie MJ; Hooper WD
    Drug Metab Dispos; 1986; 14(2):255-62. PubMed ID: 2870903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.